PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

Authors
Bate, J
Baker, S
Breuer, J
Chisholm, J
Gray, J
Hambleton, S
Houlton, A
Jit, M
Lowis, S
Makin, Guy W J
O'Sullivan, C
Patel, S
Phillips, R
Ransinghe, N
Ramsay, M
Skinner, R
Wheatley, K
Heath, P
Affiliation
Department of Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Issue Date
2018-05-05

Metadata
Show full item record
Abstract
To determine the likely rate of patient randomisation and to facilitate sample size calculation for a full-scale phase III trial of varicella zoster immunoglobulin (VZIG) and aciclovir as postexposure prophylaxis against chickenpox in children with cancer.
Citation
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. 2018, Arch Dis Child
Journal
Archives of disease in childhood
URI
http://hdl.handle.net/10541/621033
DOI
10.1136/archdischild-2017-314212
PubMed ID
29730641
Type
Article
Language
en
ISSN
1468-2044
Collections